Company: BDRX
Filing Date: 2025-01-08
Form Type: 424B3
Source: 0001214659-25-000304
Chunk: 110

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-08
Form: 424B3
Chunk 110
---
 true and correct copy of minutes of a meeting of the Board of Directors at which the Signing
Resolutions were duly adopted by the Board of Directors or a unanimous written consent adopting the Signing Resolutions executed by all
of the members of the Board of Directors. No other approvals or consents of the Board of Directors, any authorized committee thereof,
or shareholder is necessary under applicable laws and the Company’s Articles of Association to authorize the execution and delivery
of this Note.

(c) . The execution, delivery and performance of this Note by the Company and the consummation by the Company of the transactions
contemplated hereby will not (i) result in a violation of the Company’s Articles of Association or (ii) conflict with, or constitute
a default (or an event which with notice or lapse of time or both would become a default) under, or give to others any rights of termination,
amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Company or any of its Subsidiaries is
a party, or result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities laws
and regulations, the rules of the Principal Market applicable to the Company or any of its Subsidiaries) or by which any property or asset
of the Company or any of its Subsidiaries is bound or affected, except in the case of conflicts, defaults, terminations, amendments, accelerations,
cancellations and violations under clause (ii), which would not reasonably be expected to result in a Material Adverse Effect. Neither
the Company nor its Subsidiaries is in violation of any term of or in default under its Article of Association, any certificate of designation,
preferences and rights of any outstanding series of preferred stock of the Company or bylaws or other organizational documents, as applicable.
Neither the Company nor any Subsidiary: (i) is in default under or in violation of (and no event has occurred that has not been waived that, with notice or lapse of time or both, would result in a default by the Company or any Subsidiary under), nor has the Company or any Subsidiary received written notice of a claim that it is in default under or that it is in violation of, any indenture, loan or credit agreement or any other agreement or instrument to which it is a party or by which it or any of its properties is bound (whether or not such default or violation has